Palatin Presents PL8177 Ulcerative Colitis Data at Digestive Disease Week Annual Conference

– Preclinical data presented shows PL8177 was found to be efficacious in animal models of inflammatory bowel disease – Clinical data confirms PL8177 oral formulation is delivered and contained in the colon – Phase 2 clinical study data readout in 2H2023 CRANBURY, N.J., May 9, 2023…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.